Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-075788

Chief Operating Officer sold 7,714 shares at $13.00 ($100,282)

From the SEC's structured data for this filing

Trades in this filing

Dowden Nathan J · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-06-27 Sale : show line 1 in the form −7,714 $13.00 $100,282 64,893 D
Open-market sales · 7,714 sh · avg $13.00 · $100,282
Loading xslF345X03/tm2220048-2_4seq1.xml…